Trevicta 175 mg prolonged release suspension for injection)
Prolonged release suspension for injection
registration number
50/2.6.5/0699
What Trevicta 175 mg prolonged release suspension for injection) contains
paliperidone palmitate.
other ingredients
Citric acid monohydrate
Polyethylene glycol 4000
Polysorbate 20
Sodium dihydrogen phosphate monohydrate
Sodium hydroxide (for pH adjustment)
Water for injection.
Therapeutic classification
A.2.6.5 Central nervous system depressants.